KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 119 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $47,274 | -29.6% | 35,279 | -5.9% | 0.00% | – |
| Q2 2023 | $67,107 | -90.8% | 37,490 | -80.0% | 0.00% | -100.0% |
| Q1 2023 | $729,181 | -50.4% | 187,450 | -56.6% | 0.00% | -50.0% |
| Q4 2022 | $1,469,745 | +73.1% | 432,278 | +178.1% | 0.01% | +33.3% |
| Q3 2022 | $849,000 | +310.1% | 155,433 | +238.1% | 0.01% | +500.0% |
| Q2 2022 | $207,000 | -40.2% | 45,978 | -20.3% | 0.00% | -50.0% |
| Q2 2019 | $346,000 | -54.8% | 57,681 | -56.0% | 0.00% | -60.0% |
| Q1 2019 | $765,000 | +213.5% | 130,956 | +379.7% | 0.01% | +150.0% |
| Q1 2016 | $244,000 | -55.2% | 27,300 | -33.6% | 0.00% | -60.0% |
| Q4 2015 | $545,000 | +29.1% | 41,100 | +2.6% | 0.01% | +66.7% |
| Q3 2015 | $422,000 | -66.0% | 40,075 | -12.3% | 0.00% | -72.7% |
| Q2 2015 | $1,243,000 | -7.9% | 45,700 | +3.6% | 0.01% | 0.0% |
| Q1 2015 | $1,350,000 | +227.7% | 44,100 | +300.9% | 0.01% | +266.7% |
| Q4 2014 | $412,000 | – | 11,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 1,773,474 | $2,376,456 | 1.12% |
| AlphaCentric Advisors LLC | 1,125,000 | $1,507,500 | 0.86% |
| Tejara Capital Ltd | 1,077,388 | $1,443,700 | 0.82% |
| Palo Alto Investors LP | 5,675,876 | $7,605,674 | 0.72% |
| Birchview Capital, LP | 571,832 | $766,255 | 0.65% |
| Altium Capital Management LP | 740,000 | $991,600 | 0.52% |
| Avidity Partners Management LP | 8,298,570 | $11,120,084 | 0.45% |
| Worth Venture Partners, LLC | 445,981 | $597,615 | 0.36% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 561,955 | $753,020 | 0.23% |
| DAFNA Capital Management LLC | 192,678 | $258,189 | 0.08% |